Pages that link to "Q28509543"
Jump to navigation
Jump to search
The following pages link to Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha (Q28509543):
Displaying 50 items.
- Tripartite motif-containing 24 (Q21498067) (← links)
- Retinoic acid receptor, alpha (Q21984588) (← links)
- TRIM24 mediates ligand-dependent activation of androgen receptor and is repressed by a bromodomain-containing protein, BRD7, in prostate cancer cells (Q24316908) (← links)
- Trim24 targets endogenous p53 for degradation (Q24339423) (← links)
- A Structural Basis for the Assembly and Functions of a Viral Polymer that Inactivates Multiple Tumor Suppressors (Q27674473) (← links)
- Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia (Q28236628) (← links)
- Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation (Q28299905) (← links)
- Loss of the novel tumour suppressor and polarity gene Trim62 (Dear1) synergizes with oncogenic Ras in invasive lung cancer (Q28505734) (← links)
- Arterial calcifications and increased expression of vitamin D receptor targets in mice lacking TIF1alpha (Q28511092) (← links)
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation (Q28586404) (← links)
- Rhomboid domain-containing protein 3 is a negative regulator of TLR3-triggered natural killer cell activation (Q28593417) (← links)
- The polar warhead of a TRIM24 bromodomain inhibitor rearranges a water-mediated interaction network. (Q31162467) (← links)
- Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas (Q33486497) (← links)
- Estimating developmental states of tumors and normal tissues using a linear time-ordered model. (Q33817598) (← links)
- TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage (Q33899861) (← links)
- Transcription cofactors TRIM24, TRIM28, and TRIM33 associate to form regulatory complexes that suppress murine hepatocellular carcinoma (Q34181413) (← links)
- Limiting the power of p53 through the ubiquitin proteasome pathway (Q34342940) (← links)
- Making sense of ubiquitin ligases that regulate p53 (Q34503497) (← links)
- TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes (Q34744808) (← links)
- Predicting tissue specific transcription factor binding sites (Q35044479) (← links)
- Overexpression of TRIM24 is associated with the onset and progress of human hepatocellular carcinoma (Q35084843) (← links)
- TRIM32 protein sensitizes cells to tumor necrosis factor (TNFα)-induced apoptosis via its RING domain-dependent E3 ligase activity against X-linked inhibitor of apoptosis (XIAP). (Q35111028) (← links)
- Striking differences between knockout and wild-type mice in global gene expression variability (Q35169000) (← links)
- Tripartite motif 24 (Trim24/Tif1α) tumor suppressor protein is a novel negative regulator of interferon (IFN)/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor α (Rarα) inhibition (Q35312100) (← links)
- Epigenetic regulation by RARα maintains ligand-independent transcriptional activity (Q35633556) (← links)
- Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection (Q35706669) (← links)
- Loss of TRIM62 expression is an independent adverse prognostic factor in acute myeloid leukemia (Q36028489) (← links)
- Clinical significance and prognostic value of TRIM24 expression in esophageal squamous cell carcinoma (Q36149634) (← links)
- Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, meta-analysis and cross-species comparison (Q36520218) (← links)
- T-cell-intrinsic Tif1α/Trim24 regulates IL-1R expression on TH2 cells and TH2 cell-mediated airway allergy. (Q36563290) (← links)
- TRIM24 suppresses development of spontaneous hepatic lipid accumulation and hepatocellular carcinoma in mice (Q36633583) (← links)
- Genetic signatures shared in embryonic liver development and liver cancer define prognostically relevant subgroups in HCC. (Q36641420) (← links)
- Generation of mice with a conditional allele for Trim33. (Q36823455) (← links)
- Vitamin A and retinoid signaling: genomic and nongenomic effects (Q36920549) (← links)
- Liver-specific ablation of Krüppel-associated box-associated protein 1 in mice leads to male-predominant hepatosteatosis and development of liver adenoma. (Q36972688) (← links)
- Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). (Q37201722) (← links)
- TRIMming p53 for ubiquitination (Q37261753) (← links)
- RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma (Q37268965) (← links)
- A Transcriptomic Signature of Mouse Liver Progenitor Cells (Q37335215) (← links)
- Radiation carcinogenesis: lessons from Chernobyl (Q37643435) (← links)
- Retinoids regulate stem cell differentiation (Q37788067) (← links)
- The molecular physiology of nuclear retinoic acid receptors. From health to disease (Q37802557) (← links)
- Bromodomains as therapeutic targets (Q37935915) (← links)
- Heterogeneity of molecular markers in chronic myelomonocytic leukemia: a disease associated with several gene alterations. (Q37993420) (← links)
- Central role of RET in thyroid cancer (Q38167995) (← links)
- Bromodomains and their pharmacological inhibitors (Q38185355) (← links)
- Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells (Q38349181) (← links)
- Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF. (Q38668625) (← links)
- Impact of Adenovirus E4-ORF3 Oligomerization and Protein Localization on Cellular Gene Expression (Q38873678) (← links)
- Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review. (Q38874309) (← links)